| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Departments of Pharmacology and Medicine and The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick, New Jersey
Requests for reprints: Jin-Ming Yang and William N. Hait, The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08901. Phone: 732-235-8075; Fax: 732-235-8094; E-mail: jyang{at}umdnj.edu and haitwn{at}umdnj.edu.
Elongation factor-2 kinase (eEF-2 kinase), also known as Ca2+/calmodulindependent kinase III, regulates protein synthesis by controlling the rate of peptide chain elongation. The activity of eEF-2 kinase is increased in glioblastoma and other malignancies, yet its role in neoplasia is uncertain. Recent evidence suggests that autophagy plays an important role in oncogenesis and that this can be regulated by mammalian target of rapamycin (mTOR). Because eEF-2 kinase lies downstream of mTOR, we studied the role of eEF-2 kinase in autophagy using human glioblastoma cell lines. Knockdown of eEF-2 kinase by RNA interference inhibited autophagy in glioblastoma cell lines, as measured by light chain 3 (LC3)-II formation, acidic vesicular organelle staining, and electron microscopy. In contrast, overexpression of eEF-2 kinase increased autophagy. Furthermore, inhibition of autophagy markedly decreased the viability of glioblastoma cells grown under conditions of nutrient depletion. Nutrient deprivation increased eEF-2 kinase activity and decreased the activity of S6 kinase, suggesting an involvement of mTOR pathway in the eEF-2 kinase regulation of autophagy. These results suggest that eEF-2 kinase plays a regulatory role in the autophagic process in tumor cells; and eEF-2 kinase is a downstream member of the mTOR signaling; eEF-2 kinase may promote cancer cell survival under conditions of nutrient deprivation through regulating autophagy. Therefore, eEF-2 kinase may be a part of a survival mechanism in glioblastoma and targeting this kinase may represent a novel approach to cancer treatment. (Cancer Res 2006; 66(6): 3015-23)
This article has been cited by other articles:
![]() |
E. White and R. S. DiPaola The Double-Edged Sword of Autophagy Modulation in Cancer Clin. Cancer Res., September 1, 2009; 15(17): 5308 - 5316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wu, H. Zhu, D. X. Liu, T.-K. Niu, X. Ren, R. Patel, W. N. Hait, and J.-M. Yang Silencing of Elongation Factor-2 Kinase Potentiates the Effect of 2-Deoxy-D-Glucose against Human Glioma Cells through Blunting of Autophagy Cancer Res., March 15, 2009; 69(6): 2453 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chen, M. Riazy, E. M. Smith, C. G. Proud, U. P. Steinbrecher, and V. Duronio Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 92 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chu and A. J. Shatkin Apoptosis and Autophagy Induction in Mammalian Cells by Small Interfering RNA Knockdown of mRNA Capping Enzymes Mol. Cell. Biol., October 1, 2008; 28(19): 5829 - 5836. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, W. Xie, D. J. Kuhn, P. M. Voorhees, A. Lopez-Girona, D. Mendy, L. G. Corral, V. P. Krenitsky, W. Xu, L. Moutouh-de Parseval, et al. Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy Blood, May 1, 2008; 111(9): 4690 - 4699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jin, R. S. DiPaola, R. Mathew, and E. White Metabolic catastrophe as a means to cancer cell death J. Cell Sci., February 1, 2007; 120(3): 379 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meley, C. Bauvy, J. H. P. M. Houben-Weerts, P. F. Dubbelhuis, M. T. J. Helmond, P. Codogno, and A. J. Meijer AMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis J. Biol. Chem., November 17, 2006; 281(46): 34870 - 34879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hippert, P. S. O'Toole, and A. Thorburn Autophagy in Cancer: Good, Bad, or Both? Cancer Res., October 1, 2006; 66(19): 9349 - 9351. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. N. Hait, S. Jin, and J.-M. Yang A Matter of Life or Death (or Both): Understanding Autophagy in Cancer. Clin. Cancer Res., April 1, 2006; 12(7): 1961 - 1965. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |